Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Stock Symbol
-
ERNA on Nasdaq
Charles Cherington - trading volume in the past year for Ernexa Therapeutics Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
41.7M |
$4.36M |
$0.10 |
09 Jun 2025 |
Direct |
|
|
| 12.0% Senior Convertible Notes due December 12, 2028 |
0 |
|
|
29 Oct 2024 |
Direct |
Common Stock |
|
| 12.0% Senior Convertible Notes due September 24, 2025 |
0 |
|
|
29 Oct 2024 |
Direct |
Common Stock |
|
| 6.0% Senior Convertible Promissory Notes due 2028 |
0 |
|
|
29 Oct 2024 |
Direct |
Common Stock |
|
| Warrants (right to buy) |
0 |
|
|
29 Oct 2024 |
Direct |
Common Stock |
|
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.